BME Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 15:59):

Stats
Today's Volume	24 850.00
Average Volume	30 620.00
Market Cap	490.84M
Last Dividend	$0.213 ( 2024-02-14 )
Next Dividend	$0 ( N/A )
P/E	27.13
ATR14	$0.0240 (0.06%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-31	Mcclements Kyle	Buy	626	Common Stock
2024-01-31	Mcclements Kyle	Sell	626	Common Stock
2024-01-31	Mcclements Kyle	Buy	606	Phantom Shares
2024-01-31	Mcclements Kyle	Sell	266	Phantom Shares
2024-01-31	Mcclements Kyle	Sell	132	Phantom Shares

INSIDER POWER
-9.82
Last 92 transactions
Buy: 114 283 \| Sell: 124 895

Volume Correlation

Long: -0.10 (neutral)

Short: -0.26 (neutral)

Signal:(39.108) Neutral

Blackrock Health Sciences Correlation

10 Most Positive Correlations
DEH	0.857
MCK	0.856
SI-PA	0.856
SAVE	0.853
CLII	0.852
FPI	0.842
SPMO	0.84
PVL	0.84
THQ	0.837
CPNG	0.834

10 Most Negative Correlations
IVH	-0.861
TDI	-0.844
IOT	-0.842
PBC	-0.842
HRTG	-0.84
AMAM	-0.84
FPAC-UN	-0.837
NSTD-UN	-0.823
YEXT	-0.822
DGL	-0.817

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Blackrock Health Sciences Correlation - Currency/Commodity

-0.15
( neutral )

-0.23
( neutral )

0.00
( neutral )

-0.03
( neutral )

0.02
( neutral )

0.30
( neutral )

Blackrock Health Sciences Financials

Annual	2023
Revenue:	$34.90M
Gross Profit:	$28.87M (82.75 %)
EPS:	$1.440

FY	2023
Revenue:	$34.90M
Gross Profit:	$28.87M (82.75 %)
EPS:	$1.440

FY	2022
Revenue:	$-25.97M
Gross Profit:	$-31.91M (122.88 %)
EPS:	$-1.910

FY	2021
Revenue:	$59.66M
Gross Profit:	$0.00 (0.00 %)
EPS:	$5.10

Financial Reports:

No articles found.

Blackrock Health Sciences Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.639 (N/A)	$0.639 (N/A)	$0.639 (N/A)	$0.639 (N/A)	$0.639 (N/A)	$0.639 (N/A)	$0.426 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Blackrock Health Sciences Dividend Information - Dividend Royal

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.24 - Stable (4.78%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.384	2005-06-13
Last Dividend	$0.213	2024-02-14
Next Dividend	$0	N/A
Payout Date	2024-02-29
Next Payout Date	N/A
# dividends	151	--
Total Paid Out	$50.48	--
Avg. Dividend % Per Year	4.03%	--
Score	7.07	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.24
Div. Directional Score	8.19	--

Next Divdend (Est)
(2024-07-01)

$0.219 Estimate 62.33 %

Dividend Stability

1.00 Excellent

Dividend Score

7.07

Pay Frequency

Monthly

Yearly Payout

Year	Amount	Yield
2005	$1.152	4.61%
2006	$1.922	7.48%
2007	$2.07	7.64%
2008	$1.708	6.40%
2009	$1.536	7.57%
2010	$2.24	8.47%
2011	$2.50	9.36%
2012	$2.39	9.38%
2013	$3.49	12.00%
2014	$4.20	12.00%
2015	$6.71	15.90%
2016	$3.00	7.67%
2017	$2.40	7.42%
2018	$2.40	6.59%
2019	$2.40	6.38%
2020	$2.40	5.60%
2021	$2.44	5.04%
2022	$2.56	5.32%
2023	$2.56	5.89%
2024	$0.426	1.05%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.770	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0504	1.200	8.32	9.99	[0 - 0.3]
returnOnEquityTTM	0.0507	1.500	-0.548	-0.822	[0.1 - 1]
payoutRatioTTM	1.169	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	26.71	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	543.36	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	0.00880	1.500	-1.062	-1.593	[0.2 - 2]
debtRatioTTM	0.000204	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	382 316	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	1.490	2.00	9.50	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.490	2.00	9.26	10.00	[0 - 20]
debtEquityRatioTTM	0.000206	-1.500	10.00	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.846	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.539	1.000	1.215	1.215	[0.1 - 0.6]
cashFlowToDebtRatioTTM	171.16	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.0654	0.800	-2.90	-2.32	[0.5 - 2]
Total Score				11.15

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	18.13	1.000	8.27	0	[1 - 100]
returnOnEquityTTM	0.0507	2.50	-0.352	-0.822	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.490	2.00	9.50	10.00	[0 - 30]
dividendYielPercentageTTM	6.55	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.490	2.00	9.50	10.00	[0 - 30]
payoutRatioTTM	1.169	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.533	1.000	10.00	0	[0.1 - 0.5]
Total Score				5.24

Blackrock Health Sciences

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.